Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study

BACKGROUND: Combination intrapleural fibrinolytic and enzyme therapy (IET) has been established as a therapeutic option in pleural infection. Despite demonstrated efficacy, studies specifically designed and adequately powered to address complications are sparse. The safety profile, the effects of co...

Descripción completa

Detalles Bibliográficos
Autores principales: Akulian, Jason, Bedawi, Eihab O., Abbas, Hawazin, Argento, Christine, Arnold, David T., Balwan, Akshu, Batra, Hitesh, Uribe Becerra, Juan Pablo, Belanger, Adam, Berger, Kristin, Burks, Allen Cole, Chang, Jiwoon, Chrissian, Ara A., DiBardino, David M., Fuentes, Xavier Fonseca, Gesthalter, Yaron B., Gilbert, Christopher R., Glisinski, Kristen, Godfrey, Mark, Gorden, Jed A., Grosu, Horiana, Gupta, Mridul, Kheir, Fayez, Ma, Kevin C., Majid, Adnan, Maldonado, Fabien, Maskell, Nick A., Mehta, Hiren, Mercer, Joshua, Mullon, John, Nelson, Darlene, Nguyen, Elaine, Pickering, Edward M., Puchalski, Jonathan, Reddy, Chakravarthy, Revelo, Alberto E., Roller, Lance, Sachdeva, Ashutosh, Sanchez, Trinidad, Sathyanarayan, Priya, Semaan, Roy, Senitko, Michal, Shojaee, Samira, Story, Ryan, Thiboutot, Jeffrey, Wahidi, Momen, Wilshire, Candice L., Yu, Diana, Zouk, Aline, Rahman, Najib M., Yarmus, Lonny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians 2022
Materias:
Thoracic Oncology: Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773231/
https://www.ncbi.nlm.nih.gov/pubmed/35716828
http://dx.doi.org/10.1016/j.chest.2022.06.008

Ejemplares similares

Ejemplares similares